1. Home
  2. BATRA vs VKTX Comparison

BATRA vs VKTX Comparison

Compare BATRA & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

SELL

Current Price

$54.69

Market Cap

3.7B

Sector

Industrials

ML Signal

SELL

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$24.54

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRA
VKTX
Founded
2022
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
BATRA
VKTX
Price
$54.69
$24.54
Analyst Decision
Strong Buy
Analyst Count
0
21
Target Price
N/A
★ $94.50
AVG Volume (30 Days)
37.4K
★ 6.3M
Earning Date
11-04-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 26.00
N/A
EPS
★ N/A
N/A
Revenue
★ $732,492,000.00
N/A
Revenue This Year
$8.30
N/A
Revenue Next Year
$5.99
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 10.52
N/A
52 Week Low
$41.50
$24.94
52 Week High
$60.48
$43.15

Technical Indicators

Market Signals
Indicator
BATRA
VKTX
Relative Strength Index (RSI) 36.81 36.13
Support Level $54.04 N/A
Resistance Level $54.58 $35.23
Average True Range (ATR) 1.00 1.40
MACD -0.32 -0.18
Stochastic Oscillator 13.83 1.97

Price Performance

Historical Comparison
BATRA
VKTX

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: